title: Probing inhibitor-induced conformational changes along the interface between tissue factor and factor VIIa.
abstract: Upon injury of a blood vessel, activated factor VII (FVIIa) forms a high-affinity complex with its allosteric regulator, tissue factor (TF), and initiates blood clotting. Active site-inhibited factor VIIa (FVIIai) binds to TF with even higher affinity. We compared the interactions of FVIIai and FVIIa with soluble TF (sTF). Six residues in sTF were individually selected for mutagenesis and site-directed labeling. The residues are distributed along the extensive binding interface, and were chosen because they are known to interact with the different domains of FVIIa. Fluorescent and spin probes were attached to engineered Cys residues to monitor local changes in hydrophobicity, accessibility, and rigidity in the sTF--FVIIa complex upon occupation of the active site of FVIIa. The results show that inhibition of FVIIa caused the structures around the positions in sTF that interact with the protease domain of FVIIa to become more rigid and less accessible to solvent. Thus, the presence of an active site inhibitor renders the interface in this region less flexible and more compact, whereas the interface between sTF and the light chain of FVIIa is unaffected by active site occupancy.
authors.affiliation: IFM-Department of Chemistry, Linköping University, Linköping, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Osterlund
authors.forename: R
authors.initials: R
authors.lastname: Owenius
authors.forename: K
authors.initials: K
authors.lastname: Carlsson
authors.forename: U
authors.initials: U
authors.lastname: Carlsson
authors.forename: E
authors.initials: E
authors.lastname: Persson
authors.forename: M
authors.initials: M
authors.lastname: Lindgren
authors.forename: P O
authors.initials: PO
authors.lastname: Freskgård
authors.forename: M
authors.initials: M
authors.lastname: Svensson
mesh_terms: D000590:Amino Acid Chloromethyl Ketones / Q000378:metabolism; D000925:Anticoagulants / Q000378:metabolism*; D001665:Binding Sites / Q000235:genetics; D004578:Electron Spin Resonance Spectroscopy; D015942:Factor VIIa / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D005456:Fluorescent Dyes / Q000378:metabolism; D016297:Mutagenesis, Site-Directed; D009282:Naphthalenesulfonates / Q000378:metabolism; D011485:Protein Binding / Q000235:genetics; D011487:Protein Conformation; D015842:Serine Proteinase Inhibitors / Q000378:metabolism; D012995:Solubility; D013050:Spectrometry, Fluorescence; D013113:Spin Labels; D013439:Sulfhydryl Reagents / Q000378:metabolism; D013925:Thromboplastin / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism*
chemical_list: D000590:Amino Acid Chloromethyl Ketones; D000925:Anticoagulants; D005456:Fluorescent Dyes; D009282:Naphthalenesulfonates; D015842:Serine Proteinase Inhibitors; D013113:Spin Labels; D013439:Sulfhydryl Reagents; C006421:1,5-I-AEDANS; C027587:phenylalanyl-phenylalanyl-arginine chloromethyl ketone; D013925:Thromboplastin; D015942:Factor VIIa